P
Profusa
Biotech & Life Sciences · San Francisco, United States · Founded 2009
Medical devices company creating tissue-integrated sensors for chronic disease management and healthy living MoreLess
Profusa is a biotechnology company specializing in the development of biosensors that provide continuous, real-time monitoring of tissue oxygen levels. The company serves healthcare providers and researchers by offering advanced microsensing technology that can detect early signs of diseases such as chronic limb-threatening ischemia and influenza. Operating in the medical technology market, Profusa's business model focuses on the commercialization of its Oxygen Platform and glucose biosensors. The company generates revenue through the sale of these devices and related software solutions. Profusa's technology is particularly valuable for critical care management and remote patient monitoring, making it a key player in the telehealth and medical diagnostics sectors.
Keywords: biosensors, tissue oxygen, real-time monitoring, chronic ischemia, influenza detection, healthcare, telehealth, remote monitoring, medical diagnostics, biotechnology.
Talent graph
Profusa's talent
Source: Dealroom Talent Intelligence.
Investors
10 investors on Profusa's cap table
Sourced from Dealroom's funding history.
Global footprint
Where Profusa has talent and traffic
team presence
Market sentiment
What the market is saying about Profusa
An AI-synthesized read of the highest-engagement posts about Profusa on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Profusa on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.